EUCTR2005-004133-17-FI进行中（未招募）不适用
A randomised, controlled, double blind study of the immunogenicity and safety of Pediacel™, a combined diphtheria, tetanus, five component acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine (adsorbed) compared to Infanrix™–IPV+Hib when both vaccines are given to infants using a three dose immunisation schedule (Nordic schedule” 3-5-12 months)
Sanofi Pasteur Incorporated0 个研究点目标入组 800 人开始时间: 2005年10月18日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 800
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Infants aged 80 to 120 days inclusive on the day of inclusion.
- •2. Born at full term of pregnancy (>37 weeks).
- •3. Informed consent form signed by the parent(s) or other legal representative according to local regulations.
- •4. Parent(s) or legal representative able to attend all scheduled visits and to understand and comply with the study procedures (able to read and write; access to a telephone).
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Rectal temperature =38.0°C
- •2. Moderate or severe acute illness with or without fever
- •3. Participation in another clinical trial in the 4 weeks preceding the first trial vaccination.
- •4. Having received any DTaP, IPV, or Hib vaccines prior to study initiation or any vaccination in the 4 weeks preceding the first trial vaccination.
- •5. Planned participation in another clinical trial during the present trial period.
- •6. Known history of diphtheria, tetanus, pertussis, H. influenzae type b infections, poliomyelitis.
- •7. Congenital or acquired immunodeficiency, immunosuppressive therapy such as long-term systemic corticosteroids therapy.
- •8. Systemic hypersensitivity to any of the vaccine components (including neomycin, streptomycin, polymyxin B and formaldehyde).
- •9. History of a life-threatening reaction (such as encephalopathy, Hypotonic Hyporesponsive Episode, severe fever, convulsions, etc.) to the trial vaccine or a vaccine containing the same substances.
- •10. Blood or blood-derived products (immunoglobulins) received in the past 4 weeks.
- •11. Vaccination planned in the 6 weeks following any trial vaccination.
- •12. Known HIV seropositivity.
- •13. Thrombocytopenia or a bleeding disorder contraindicating intramuscular vaccination.
- •14. History of seizures or progressive, evolving or unstable neurological condition.
- •15. Clinically significant findings on review of systems that might interfere with correct vaccination or which, in the opinion of the Investigator, would interfere with the evaluation of the vaccine or pose a health risk to the subject (determined by the Investigator or sub-Investigator to be sufficient for exclusion).
研究者
相似试验
进行中（未招募）
不适用
A randomised, controlled, double blind study of the immunogenicity and safety of PEDIACEL®, a combined diphtheria, tetanus, five component acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate vaccine (adsorbed) compared to Infanrix™–IPV+Hib when both vaccines are given to infants using a three dose immunisation schedule (Nordic schedule” 3-5-12 months)PEDIACEL® is a fully liquid combination vaccine indicated for infants from 2 months of age to protect against diseases caused by 5 common pathogens: Haemophilus influenzae type b, Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis, and poliovirus types 1, 2 and 3.EUCTR2005-004133-17-SESanofi Pasteur Incorporated800
已完成
不适用
A randomised, double-blind, controlled study on the effect of one year administration of a nutritional concept on immunological status in human immunodeficiency virus-1 positive adults not on anti-retroviral therapyHIVInfections and InfestationsISRCTN81868024umico Research B.V. (The Netherlands)800
招募中
3 期
Macrolide treatment of Non-Eosinophilic AsthmaAsthmaACTRN12605000318684Hunter New England Area Health Service64
尚未招募
4 期
Study for assessing technique for pain relief in children undergoing cleft lip surgery.CTRI/2023/03/050425SRM
已完成
3 期
Azithromycin in older people with airway diseaseChronic obstructive pulmonary diseaseRespiratory - Chronic obstructive pulmonary diseaseRespiratory - AsthmaAsthmaACTRN12609000259246Hunter New England Area Health Service40